Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN vs ROMOSOZUMAB-AQQG: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIZATRIPTAN vs ROMOSOZUMAB-AQQG: Safety Overview

Metric RIZATRIPTAN ROMOSOZUMAB-AQQG
Total FAERS Reports 2,896 11,361
Deaths Reported 68 633
Death Rate 2.3% 5.6%
Hospitalizations 479 2,717
Average Patient Age 44.6 yrs 74.7 yrs
% Female Patients 77.2% 92.9%
FDA Approval Date Apr 14, 2023 N/A
Manufacturer Panacea Biotec Limited N/A
Route ORAL N/A
Marketing Status Discontinued Prescription